Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2019 | Story Rulanzen Martin | Photo Jolandi Griesel
Dr Whitty Green, Dr Engela van Staden and Prof Francois Strydom
Dr Whitty Green, Dr Engela van Staden and Prof Francois Strydom, Senior Director of CTL.

Data, quality, and capacity building were among the main topics of discussion at the third annual Teaching and Learning Conference hosted by the Centre for Teaching and Learning at the University of the Free State (UFS).

Dr Engela van Staden, Vice-Rector: Academic, welcomed delegates on the first day of the conference. The three themes of the conference were quality, capacity and excellence. “These three constructs have never been more relevant in South African higher education than now,’ said Dr Van Staden. “The quality of education, globally, and specifically in SA, is being questioned. Both public and private sectors are demanding graduates that need to meet the challenges of the 21st Century.” 

The aim of the teaching and learning conference is to foster more collaboration between academics at the UFS. A total of 14 academics from across all seven faculties presented during the two-day conference. Dr Whitty Green from the Department of Higher Education and Training (DHET) delivered the keynote on the first day and Prof Corlia Janse van Vuuren delivered the second day keynote.

The inclusion of technology in the world of work and the use of data analytics are fundamentally confronting our learning and teaching place. “And I hope some of the issues will be addressed in the presentations,” Dr Van Staden said. 

Bringing down silos of research and teaching

Dr Green spoke about the Enacting the National Framework for Enhancing Academics as University Teachers. “Academics are teachers and researchers and they have to engage with the community. There are multiple roles and these roles intersect,” Dr Green said. In order to build capacity in the system it is important to understand the multiple natures of the roles and try to work with them. This is the reason why the teaching development grant and teaching grant have been pulled together to form the University Capacity Grant. “We are trying to break down the silos of research development and teaching development at universities,” he said.

Prof Janse van Vuuren, Head of the UFS School of Allied Health Professionals, delivered her keynote address on Quality, Capacity and Excellence: Dotting the Is and crossing the Ts in a changing, data-driven Higher Education Environment. She shared her story to establish a faculty-based operational framework for teaching and learning.

“I did not know how to bring all of the issues ranging from research, teaching and learning and student success into one framework,” said Prof Janse van Vuuren. She developed a faculty-based operational framework for teaching and learning for the Faculty of Economic and Management Sciences.

The third annual UFS Teaching and Learning Conference took place from 26 to 27 March 2019.



News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept